Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$58.44 -1.56 (-2.60%)
At close: Oct 1, 2026 · 4:00 PM EDT

Biomarin Pharmaceutical (BMRN) Change in Receivables (2009 - 2026)

Updated

Biomarin Pharmaceutical's Change in Receivables was $38.85 million in Q2 2026, down 60.6% from $98.53 million a year earlier but up 442.6% from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Change in Receivables (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Biomarin Pharmaceutical's Change in Receivables was $117.94 million through Jun 30, 2026, down 25.3% year-over-year; for FY2025, it was $228.05 million, up 293.8% from FY2024.

  • Change in Receivables shows a five-year compound annual growth rate of 31.0% (FY2020 to FY2025).
  • In earlier years, Change in Receivables was $57.91 million in FY2024 (-69.6%), $190.44 million in FY2023 (+132.1%), $82.03 million in FY2022 and -$65.57 million in FY2021.
  • Quarterly Change in Receivables has moved between -$72.55 million (Q4 2024) and $138.8 million (Q1 2023) over five years.
  • The best year-over-year quarter for Change in Receivables over five years was Q2 2024 (growth of 649.0%); the worst was Q1 2024 (a decline of 97.6%).
  • Per Business Quant data, BMRN's Change in Receivables in the three quarters before Q2 2026 was $7.16 million (Q1 2026), $120.68 million (Q4 2025) and -$48.75 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Biomarin Pharmaceutical 11.61 Bn 5.48 Bn 786.91 Mn 38.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38.85 Mn
Mar 31, 2026 7.16 Mn
Dec 31, 2025 120.68 Mn
Sep 30, 2025 -48.75 Mn
Jun 30, 2025 98.53 Mn
Mar 31, 2025 57.59 Mn
Dec 31, 2024 -72.55 Mn
Sep 30, 2024 74.38 Mn
Jun 30, 2024 52.70 Mn
Mar 31, 2024 3.39 Mn
Dec 31, 2023 58.50 Mn
Sep 30, 2023 -13.89 Mn
Jun 30, 2023 7.04 Mn
Mar 31, 2023 138.80 Mn
Dec 31, 2022 28.28 Mn
Sep 30, 2022 -38.81 Mn
Jun 30, 2022 37.75 Mn
Mar 31, 2022 54.81 Mn
Dec 31, 2021 -61,000.00
Sep 30, 2021 -48.09 Mn
API Access

Biomarin Pharmaceutical Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=BMRN&period=max&api_key=YOUR_API_KEY